According to documents submitted to the U.S. Securities and Exchange Commission, Cerus Corporation has announced that William Greenman will step down as the company's President and Chief Executive Officer, effective July 1, 2026.

At that time, he will assume the position of Executive Chairman of the company. This senior management change marks a major adjustment in the company’s leadership structure. After stepping down from operational duties, Greenman will continue to participate in the company's strategic guidance and governance as Executive Chairman. Cerus focuses on blood safety and blood therapies. This management change is expected to bring new perspectives and direction to the company's next stage of development.